bladder disease |
Disease ID | 1582 |
---|---|
Disease | bladder disease |
Integrated Phenotype | (Waiting for update.) |
Text Mined Phenotype | HPO | Name | Sentences' Count(Total Phenotypes:14) HP:0001081 | Gallstones | 2 HP:0000716 | Depression | 1 HP:0002664 | Neoplasia | 1 HP:0008711 | Benign prostatic hypertrophy | 1 HP:0001513 | Obesity | 1 HP:0000012 | Urinary urgency | 1 HP:0001297 | Cerebral vascular events | 1 HP:0001082 | Cholecystitis | 1 HP:0100790 | Hernia | 1 HP:0001394 | Hepatic cirrhosis | 1 HP:0001537 | Umbilical hernias | 1 HP:0002758 | Osteoarthritis | 1 HP:0003077 | Hyperlipidemia | 1 HP:0009725 | Bladder neoplasm | 1 |
Disease ID | 1582 |
---|---|
Disease | bladder disease |
Manually Symptom | (Waiting for update.) |
Text Mined Symptom | (Waiting for update.) |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
All Snps(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Annotation(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Snp Trait(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
Mapped by lexical matching(Total Items:0) |
---|
(Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
---|
(Waiting for update.) |
Chemical(Total Drugs:19) | |||||||||
---|---|---|---|---|---|---|---|---|---|
CUI | ChemicalName | ChemicalID | CasRN | DiseaseName | DiseaseID | DirectEvidence | PubMedIDs | ||
C0005686 | bupivacaine | D002045 | 2180-92-9 | urinary bladder diseases | MESH:D001745 | marker/mechanism | 9570608 | ||
C0005686 | capsaicin | D002211 | 404-86-4 | urinary bladder diseases | MESH:D001745 | therapeutic | 8032584 | ||
C0005686 | carboprost tromethamine | C062843 | 58551-69-2 | urinary bladder diseases | MESH:D001745 | marker/mechanism | 12956853 | ||
C0005686 | cyclophosphamide | D003520 | 50-18-0 | urinary bladder diseases | MESH:D001745 | marker/mechanism | 10680587 | ||
C0005686 | cisplatin | D002945 | 15663-27-1 | urinary bladder diseases | MESH:D001745 | marker/mechanism | 21291546 | ||
C0005686 | epirubicin | D015251 | 56420-45-2 | urinary bladder diseases | MESH:D001745 | marker/mechanism | 7598036 | ||
C0005686 | fluorouracil | D005472 | 51-21-8 | urinary bladder diseases | MESH:D001745 | marker/mechanism | 21291546 | ||
C0005686 | glutathione | D005978 | 70-18-8 | urinary bladder diseases | MESH:D001745 | marker/mechanism | 7548731 | ||
C0005686 | glutathione | D005978 | 70-18-8 | urinary bladder diseases | MESH:D001745 | therapeutic | 2773078 | ||
C0005686 | icatibant | C065679 | 130308-48-4 | urinary bladder diseases | MESH:D001745 | therapeutic | 8032584 | ||
C0005686 | ifosfamide | D007069 | 3778-73-2 | urinary bladder diseases | MESH:D001745 | marker/mechanism | 16947012 | ||
C0005686 | indomethacin | D007213 | 53-86-1 | urinary bladder diseases | MESH:D001745 | therapeutic | 8486095 | ||
C0005686 | masoprocol | D009637 | - | urinary bladder diseases | MESH:D001745 | therapeutic | 8486095 | ||
C0005686 | mesna | D015080 | 19767-45-4 | urinary bladder diseases | MESH:D001745 | therapeutic | 19696094 | ||
C0005686 | mitomycin | D016685 | 1950/7/7 | urinary bladder diseases | MESH:D001745 | marker/mechanism | 1807206 | ||
C0005686 | mitoxantrone | D008942 | 65271-80-9 | urinary bladder diseases | MESH:D001745 | marker/mechanism | 18510180 | ||
C0005686 | nicotine | D009538 | - | urinary bladder diseases | MESH:D001745 | marker/mechanism | 15025861 | ||
C0005686 | streptozocin | D013311 | 18883-66-4 | urinary bladder diseases | MESH:D001745 | marker/mechanism | 17989502 | ||
C0005686 | vincristine | D014750 | - | urinary bladder diseases | MESH:D001745 | marker/mechanism | 15891567 |
FDA approved drug and dosage information(Total Drugs:0) | |
---|---|
(Waiting for update.) |
FDA labeling changes(Total Drugs:0) | |
---|---|
(Waiting for update.) |